UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma

PloS one, 2010-08, Vol.5 (8), p.e12419-e12419

2010

Volltextzugriff (PDF)

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

The American journal of gastroenterology, 1999-09, Vol.94 (9), p.2467-2474

1999

Volltextzugriff (PDF)

Editorial: Feeling better about NASH

Alimentary pharmacology & therapeutics, 2023-08, Vol.58 (4), p.482-483

Di Bisceglie, Adrian M

2023

Volltextzugriff (PDF)

Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial

The American journal of gastroenterology, 2023-07, Vol.118 (7), p.1226-1236

2023

Volltextzugriff (PDF)

A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis

The American journal of gastroenterology, 2022-11, Vol.117 (11), p.1805-1815

2022

Volltextzugriff (PDF)

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.115-126

2017

Volltextzugriff (PDF)

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

PloS one, 2018-08, Vol.13 (8), p.e0196908-e0196908

2018

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

Lipids in health and disease, 2020-11, Vol.19 (1), p.1-10, Article 239

2020

Volltextzugriff (PDF)

Review article: Recommendations for detection, assessment and management of suspected drug‐induced liver injury during clinical trials in oncology patients

Alimentary pharmacology & therapeutics, 2024-11, Vol.60 (10), p.1293-1307

2024

Volltextzugriff (PDF)

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components

PloS one, 2014-07, Vol.9 (7), p.e101422-e101422

2014

Volltextzugriff (PDF)

Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy

BMC infectious diseases, 2020-08, Vol.20 (1), p.1-632, Article 632

2020

Volltextzugriff (PDF)

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

PloS one, 2010-02, Vol.5 (2), p.e9032

2010

Volltextzugriff (PDF)

A novel target enrichment strategy in next-generation sequencing through 7-deaza-dGTP-resistant enzymatic digestion

BMC research notes, 2020-09, Vol.13 (1), p.445-445, Article 445

2020

Volltextzugriff (PDF)

Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B

The American journal of gastroenterology, 2023-07, Vol.118 (7), p.1214-1225

2023

Volltextzugriff (PDF)

Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals

Journal of general internal medicine : JGIM, 2020-04, Vol.35 (4), p.1011-1020

2020

Volltextzugriff (PDF)

High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy

PloS one, 2014-06, Vol.9 (6), p.e100131

2014

Volltextzugriff (PDF)

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

PloS one, 2013-06, Vol.8 (6), p.e64992-e64992

2013

Volltextzugriff (PDF)

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.1001-1011

2018

Volltextzugriff (PDF)

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2010-04, Vol.31 (7), p.719-734

2010

Volltextzugriff (PDF)

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status

The American journal of gastroenterology, 2003-09, Vol.98 (9), p.2060-2063

2003

Volltextzugriff (PDF)

Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

Hepatology (Baltimore, Md.), 1991-12, Vol.14 (6), p.969-974

1991

Volltextzugriff (PDF)

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Oncology reports, 2006-07, Vol.16 (1), p.133-140

2006

Volltextzugriff (PDF)

Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia

The American journal of gastroenterology, 2019-11, Vol.114 (11), p.1753-1763

2019

Volltextzugriff (PDF)

Clinical presentation and natural course of hepatocellular carcinoma

European journal of gastroenterology & hepatology, 2005-05, Vol.17 (5), p.485-489

2005

Volltextzugriff (PDF)

Phenotypes of Chronic Hepatitis B in Children From a Large North American Cohort

Journal of pediatric gastroenterology and nutrition, 2019-11, Vol.69 (5), p.588-594

2019

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Aktive Filter

KollektionIEEE Xplore Digital Library

KollektionTaylor & Francis Online

Zeitschrift / SerieGastroenterology

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(104)

Sprache

Englisch
(104)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

Editorial: Feeling better about NASH

Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial

A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

Review article: Recommendations for detection, assessment and management of suspected drug‐induced liver injury during clinical trials in oncology patients

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components

Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

A novel target enrichment strategy in next-generation sequencing through 7-deaza-dGTP-resistant enzymatic digestion

Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B

Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals

High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status

Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia

Clinical presentation and natural course of hepatocellular carcinoma

Phenotypes of Chronic Hepatitis B in Children From a Large North American Cohort

Aktive Filter

Suchergebnisse filtern